Geoffrey A. Swire

Chief Operating Officer at ALLENA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Geoffrey A.
Swire is currently the COO & Senior Vice President-Corporate Development at Allena Pharmaceuticals, Inc. He previously worked as the Head-Program & Portfolio Management at Genzyme Corp.
and as the Head-Business Development & Alliance Management at Radius Health, Inc. He completed his undergraduate degree at Dartmouth College and his graduate degree at Harvard University.

Geoffrey A. Swire active positions

Companies	Position	Start
ALLENA PHARMACEUTICALS, INC.	Chief Operating Officer	2020-11-09

All active positions of Geoffrey A. Swire

Former positions of Geoffrey A. Swire

Companies	Position	End
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
RADIUS HEALTH, INC.	Corporate Officer/Principal	-

See the detail of Geoffrey A. Swire's experience

Training of Geoffrey A. Swire

Dartmouth College	Undergraduate Degree
Harvard University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Geoffrey A. Swire's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ALLENA PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology